Long Acting Beta-2 Agonists in the Treatment of Asthma and Their Safety

Tuberkuloz ve Toraks - Turkey
doi 10.5578/tt.3269
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bilimsel Tip Publishing House

Related search

Long-Acting 2-Agonists in Asthma: Safety Concerns

CMAJ
Medicine
2005English

Prs1 Severe Asthma Exacerbations Associated With Long-Acting Beta Agonists Among Children and Adolescents With Asthma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Addition of Long-Acting Beta-Agonists to Inhaled Corticosteroids for Chronic Asthma in Children

2009English

Review: Regular Inhaled Long Acting 2 Agonists Are Associated With Better Outcomes Than Short Acting 2 Agonists in Adults and Children With Chronic Asthma

Evidence-based nursing
FundamentalsSkills
2003English

The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma

Barcelona Respiratory Network
2017English

The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma

Barcelona Respiratory Network
2017English

Systematic Review and Economic Analysis of the Comparative Effectiveness of Different Inhaled Corticosteroids and Their Usage With Long-Acting Beta 2 Agonists for the Treatment of Chronic Asthma in Children Under the Age of 12 Years

Clinical Governance: An International Journal
2009English

Reply: Adverse Effects of Long-Acting Beta-Agonists on Airway Hyperresponsiveness

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2013English

Do Long-Acting Β2-Adrenoceptor Agonists Enhance the Anti-Inflammatory Effect of Glucocorticoids in Asthma?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy